IMB-H-4

N/A

Report date: 2022/01/10 18:08:27
NME

Base Information

Drug NameIMB-H-4
Drug Alias NameIMB-H-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial outer membrane proteins inhibitors
TargetsBacterial outer membrane proteins
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A